Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 22% ± 7% | |
epithelial cell | 4 studies | 23% ± 6% | |
macrophage | 4 studies | 18% ± 2% | |
astrocyte | 4 studies | 26% ± 6% | |
glutamatergic neuron | 4 studies | 33% ± 16% | |
oligodendrocyte | 4 studies | 21% ± 3% | |
microglial cell | 3 studies | 20% ± 2% | |
transit amplifying cell | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1281.83 | 1444 / 1445 | 100% | 13.87 | 183 / 183 |
lung | 99% | 1162.28 | 575 / 578 | 99% | 8.85 | 1145 / 1155 |
breast | 100% | 1372.29 | 459 / 459 | 98% | 12.66 | 1094 / 1118 |
brain | 99% | 901.65 | 2624 / 2642 | 98% | 9.13 | 692 / 705 |
intestine | 100% | 1553.03 | 966 / 966 | 96% | 7.27 | 506 / 527 |
stomach | 100% | 904.80 | 359 / 359 | 95% | 8.73 | 273 / 286 |
uterus | 100% | 1653.97 | 170 / 170 | 95% | 10.87 | 438 / 459 |
bladder | 100% | 1385.19 | 21 / 21 | 94% | 7.51 | 476 / 504 |
thymus | 100% | 1351.52 | 653 / 653 | 94% | 7.31 | 571 / 605 |
ovary | 100% | 1328.67 | 180 / 180 | 94% | 6.04 | 405 / 430 |
pancreas | 98% | 651.02 | 323 / 328 | 95% | 5.77 | 169 / 178 |
prostate | 100% | 1208.06 | 245 / 245 | 89% | 6.30 | 446 / 502 |
kidney | 100% | 794.03 | 89 / 89 | 87% | 5.18 | 780 / 901 |
adrenal gland | 100% | 887.47 | 257 / 258 | 87% | 4.64 | 199 / 230 |
skin | 100% | 1321.10 | 1805 / 1809 | 82% | 6.99 | 388 / 472 |
liver | 99% | 475.85 | 223 / 226 | 61% | 2.64 | 247 / 406 |
blood vessel | 100% | 1478.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1293.62 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1363.65 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1070.29 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 771.40 | 836 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.22 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 72% | 6.31 | 21 / 29 |
peripheral blood | 55% | 750.82 | 512 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 35% | 1.55 | 28 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0036337 | Biological process | Fas signaling pathway |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016605 | Cellular component | PML body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0005123 | Molecular function | death receptor binding |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0016505 | Molecular function | peptidase activator activity involved in apoptotic process |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0032184 | Molecular function | SUMO polymer binding |
Gene name | CASP8AP2 |
Protein name | CASP8-associated protein 2 (FLICE-associated huge protein) CASP8AP2 protein Alternative protein CASP8AP2 Caspase 8 associated protein 2 |
Synonyms | RIP25 FLASH KIAA1315 |
Description | FUNCTION: Participates in TNF-alpha-induced blockade of glucocorticoid receptor (GR) transactivation at the nuclear receptor coactivator level, upstream and independently of NF-kappa-B. Suppresses both NCOA2- and NCOA3-induced enhancement of GR transactivation. Involved in TNF-alpha-induced activation of NF-kappa-B via a TRAF2-dependent pathway. Acts as a downstream mediator for CASP8-induced activation of NF-kappa-B. Required for the activation of CASP8 in FAS-mediated apoptosis. Required for histone gene transcription and progression through S phase. . |
Accessions | A0A087WTW5 Q9UKL3 ENST00000671703.2 ENST00000419040.6 L8EC81 ENST00000552401.5 ENST00000551025.4 A0A096LP21 A7E2C0 |